These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37639579)

  • 1. Incompatible plasma transfusion is not associated with increased mortality in civilian trauma patients.
    Donohue JK; Sperry JL; Spinella PC; Triulzi DJ; Leeper CL; Yazer MH
    Hematology; 2023 Dec; 28(1):2250647. PubMed ID: 37639579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion of blood components containing ABO-incompatible plasma does not lead to higher mortality in civilian trauma patients.
    Seheult JN; Dunbar NM; Hess JR; Tuott EE; Bahmanyar M; Campbell J; Fontaine M; Khan J; Ko A; Mi J; Murphy MF; Nykoluk T; Poisson J; Raval JS; Shih A; Sperry JL; Staves J; Wong M; Yan MTS; Ziman A; Yazer MH;
    Transfusion; 2020 Nov; 60(11):2517-2528. PubMed ID: 32901965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile of uncrossmatched, cold-stored, low-titer, group O+ whole blood in civilian trauma patients.
    Seheult JN; Bahr M; Anto V; Alarcon LH; Corcos A; Sperry JL; Triulzi DJ; Yazer MH
    Transfusion; 2018 Oct; 58(10):2280-2288. PubMed ID: 29802644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion of ABO-group identical red blood cells following uncrossmatched transfusion does not lead to higher mortality in civilian trauma patients.
    Yazer MH; Dunbar NM; Hess JR; Tuott EE; Bahmanyar M; Campbell J; Fontaine M; Ko A; Mi J; Murphy MF; Poisson J; Raval JS; Shih AW; Sperry JL; Staves J; Wong M; Yan MTS; Ziman A; Seheult JN
    Transfusion; 2023 May; 63 Suppl 3():S46-S53. PubMed ID: 36971017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of at least 4 units of low titer group O whole blood with titer <100 does not lead to hemolysis in adult trauma patients.
    Yazer MH; Corcos A; L Sperry J; Triulzi DJ; Leeper C
    Transfusion; 2022 Aug; 62 Suppl 1():S72-S79. PubMed ID: 35748690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of stored low titer group O whole blood + component therapy versus component therapy only for civilian trauma patients.
    Siletz AE; Blair KJ; Cooper RJ; Nguyen NC; Lewis SJ; Fang A; Ward DC; Jackson NJ; Rodriguez T; Grotts J; Hwang J; Ziman A; Cryer HM
    J Trauma Acute Care Surg; 2021 Oct; 91(4):655-662. PubMed ID: 34225348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rebirth of the cool: a narrative review of the clinical outcomes of cold stored low titer group O whole blood recipients compared to conventional component recipients in trauma.
    Dishong D; Cap AP; Holcomb JB; Triulzi DJ; Yazer MH
    Hematology; 2021 Dec; 26(1):601-611. PubMed ID: 34411495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes among low-titer group O whole blood recipients compared to recipients of conventional components in civilian trauma resuscitation.
    Seheult JN; Anto V; Alarcon LH; Sperry JL; Triulzi DJ; Yazer MH
    Transfusion; 2018 Aug; 58(8):1838-1845. PubMed ID: 30160310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic markers following the transfusion of uncrossmatched, cold-stored, low-titer, group O+ whole blood in civilian trauma patients.
    Harrold IM; Seheult JN; Alarcon LH; Corcos A; Sperry JL; Triulzi DJ; Yazer MH
    Transfusion; 2020 Jun; 60 Suppl 3():S24-S30. PubMed ID: 32478860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events after low titer group O whole blood versus component product transfusion in pediatric trauma patients: A propensity-matched cohort study.
    Leeper CM; Yazer MH; Morgan KM; Triulzi DJ; Gaines BA
    Transfusion; 2021 Sep; 61(9):2621-2628. PubMed ID: 34047385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incompatible type A plasma transfusion in patients requiring massive transfusion protocol: Outcomes of an Eastern Association for the Surgery of Trauma multicenter study.
    Stevens WT; Morse BC; Bernard A; Davenport DL; Sams VG; Goodman MD; Dumire R; Carrick MM; McCarthy P; Stubbs JR; Pritts TA; Dente CJ; Luo-Owen X; Gregory JA; Turay D; Gomaa D; Quispe JC; Fitzgerald CA; Haddad NN; Choudhry A; Quesada JF; Zielinski MD
    J Trauma Acute Care Surg; 2017 Jul; 83(1):25-29. PubMed ID: 28452877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of haemolysis markers following transfusion of uncrossmatched, low-titre, group O+ whole blood in civilian trauma patients: initial experience at a level 1 trauma centre.
    Seheult JN; Triulzi DJ; Alarcon LH; Sperry JL; Murdock A; Yazer MH
    Transfus Med; 2017 Feb; 27(1):30-35. PubMed ID: 27730689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of ABO-Incompatible Plasma From Non-ABO-Identical Components.
    Ruby KN; Harm SK; Dunbar NM
    Transfus Med Rev; 2021 Oct; 35(4):118-122. PubMed ID: 34544619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Titer Group O Whole Blood In Injured Children Requiring Massive Transfusion.
    Gaines BA; Yazer MH; Triulzi DJ; Sperry JL; Neal MD; Billiar TR; Leeper CM
    Ann Surg; 2023 Apr; 277(4):e919-e924. PubMed ID: 35129530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receipt of low titer group O whole blood does not lead to hemolysis in children weighing less than 20 kilograms.
    Abou Khalil E; Gaines BA; Morgan KM; Spinella PC; Yazer MH; Triulzi DJ; Leeper CM
    Transfusion; 2023 May; 63 Suppl 3():S18-S25. PubMed ID: 36971012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy of Low-Titer Group O Whole Blood Compared With Component Therapy in Civilian Trauma Patients: A Meta-Analysis.
    Morgan KM; Abou Khalil E; Feeney EV; Spinella PC; Lucisano AC; Gaines BA; Leeper CM
    Crit Care Med; 2024 Jul; 52(7):e390-e404. PubMed ID: 38483205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injured recipients of low-titer group O whole blood have similar clinical outcomes compared to recipients of conventional component therapy: A single-center, retrospective study.
    Yazer MH; Freeman A; Harrold IM; Anto V; Neal MD; Triulzi DJ; Sperry JL; Seheult JN
    Transfusion; 2021 Jun; 61(6):1710-1720. PubMed ID: 33811640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of low-titer O whole blood resuscitation in a civilian level I trauma center.
    Kemp Bohan PM; McCarthy PM; Wall ME; Adams AM; Chick RC; Forcum JE; Radowsky JS; How RA; Sams VG
    J Trauma Acute Care Surg; 2021 Aug; 91(2S Suppl 2):S162-S168. PubMed ID: 34039931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prehospital low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial.
    Guyette FX; Zenati M; Triulzi DJ; Yazer MH; Skroczky H; Early BJ; Adams PW; Brown JB; Alarcon L; Neal MD; Forsythe RM; Zuckerbraun BS; Peitzman AB; Billiar TR; Sperry JL
    J Trauma Acute Care Surg; 2022 May; 92(5):839-847. PubMed ID: 35081595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of low-titer group O whole blood is independently associated with improved survival compared to component therapy in adults with severe traumatic hemorrhage.
    Shea SM; Staudt AM; Thomas KA; Schuerer D; Mielke JE; Folkerts D; Lowder E; Martin C; Bochicchio GV; Spinella PC
    Transfusion; 2020 Jun; 60 Suppl 3():S2-S9. PubMed ID: 32478896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.